<?xml version="1.0" encoding="UTF-8"?>
<compound>
  <id type="integer">345890</id>
  <title nil="true"/>
  <common-name>4-hydroxy-7-[(5-hydroxy-7-sulfonaphthalen-2-yl)carbamoylamino]-3-phenyldiazenylnaphthalene-2-sulfonic acid</common-name>
  <description>4-hydroxy-7-[(5-hydroxy-7-sulfonaphthalen-2-yl)carbamoylamino]-3-phenyldiazenylnaphthalene-2-sulfonic acid has the chemical formula C27H20N4O9S2. With an average molecular weight of 608.60 g/mol, 4-hydroxy-7-[(5-hydroxy-7-sulfonaphthalen-2-yl)carbamoylamino]-3-phenyldiazenylnaphthalene-2-sulfonic acid is a heavy molecule.</description>
  <cas nil="true"/>
  <pubchem-id>103309</pubchem-id>
  <chemical-formula>C27H20N4O9S2</chemical-formula>
  <weight>608.6</weight>
  <appearance nil="true"/>
  <melting-point nil="true"/>
  <boiling-point nil="true"/>
  <density nil="true"/>
  <solubility nil="true"/>
  <specific-gravity nil="true"/>
  <flash-point nil="true"/>
  <vapour-pressure nil="true"/>
  <route-of-exposure nil="true"/>
  <target nil="true"/>
  <mechanism-of-toxicity nil="true"/>
  <metabolism nil="true"/>
  <toxicity nil="true"/>
  <lethaldose nil="true"/>
  <carcinogenicity nil="true"/>
  <use-source nil="true"/>
  <min-risk-level nil="true"/>
  <health-effects nil="true"/>
  <symptoms nil="true"/>
  <treatment nil="true"/>
  <created-at type="dateTime">2026-08-31T08:55:42Z</created-at>
  <updated-at type="dateTime">2026-08-31T08:55:42Z</updated-at>
  <interacting-proteins nil="true"/>
  <wikipedia nil="true"/>
  <uniprot-id nil="true"/>
  <kegg-compound-id nil="true"/>
  <omim-id nil="true"/>
  <chebi-id nil="true"/>
  <biocyc-id nil="true"/>
  <ctd-id nil="true"/>
  <stitch-id nil="true"/>
  <drugbank-id nil="true"/>
  <pdb-id nil="true"/>
  <actor-id nil="true"/>
  <organism nil="true"/>
  <export type="boolean">true</export>
  <metabolizing-proteins nil="true"/>
  <transporting-proteins nil="true"/>
  <moldb-smiles>C1=CC=C(C=C1)N=NC2=C(C=C3C=C(C=CC3=C2O)NC(=O)NC4=CC5=CC(=CC(=C5C=C4)O)S(=O)(=O)O)S(=O)(=O)O</moldb-smiles>
  <moldb-formula>C27H20N4O9S2</moldb-formula>
  <moldb-inchi>InChI=1S/C27H20N4O9S2/c32-23-14-20(41(35,36)37)12-15-10-18(6-8-21(15)23)28-27(34)29-19-7-9-22-16(11-19)13-24(42(38,39)40)25(26(22)33)31-30-17-4-2-1-3-5-17/h1-14,32-33H,(H2,28,29,34)(H,35,36,37)(H,38,39,40)</moldb-inchi>
  <moldb-inchikey>SFKWASULANNHDT-UHFFFAOYSA-N</moldb-inchikey>
  <moldb-average-mass type="decimal" nil="true"/>
  <moldb-mono-mass type="decimal">608.0671706</moldb-mono-mass>
  <origin nil="true"/>
  <state nil="true"/>
  <logp>3.5</logp>
  <hmdb-id nil="true"/>
  <chembl-id nil="true"/>
  <chemspider-id nil="true"/>
  <structure-image-file-name nil="true"/>
  <structure-image-content-type nil="true"/>
  <structure-image-file-size type="integer" nil="true"/>
  <structure-image-updated-at type="dateTime" nil="true"/>
  <biodb-id nil="true"/>
  <synthesis-reference nil="true"/>
  <structure-image-caption nil="true"/>
  <chemdb-id>CHEM341783</chemdb-id>
  <dsstox-id nil="true"/>
  <toxcast-id nil="true"/>
  <stoff-ident-origin nil="true"/>
  <stoff-ident-id nil="true"/>
  <susdat-id nil="true"/>
  <iupac>4-hydroxy-7-[(5-hydroxy-7-sulfonaphthalen-2-yl)carbamoylamino]-3-phenyldiazenylnaphthalene-2-sulfonic acid</iupac>
  <moldb-polar-surface-area nil="true"/>
  <moldb-refractivity nil="true"/>
  <moldb-polarizability nil="true"/>
  <moldb-rotatable-bond-count nil="true"/>
  <moldb-acceptor-count nil="true"/>
  <moldb-donor-count nil="true"/>
  <moldb-pka-strongest-acidic nil="true"/>
  <moldb-pka-strongest-basic nil="true"/>
  <moldb-physiological-charge nil="true"/>
  <moldb-number-of-rings nil="true"/>
  <moldb-alogps-logp nil="true"/>
  <moldb-alogps-logs nil="true"/>
  <moldb-alogps-solubility nil="true"/>
  <kingdom>Organic compounds</kingdom>
  <superklass>Benzenoids</superklass>
  <klass>Naphthalenes</klass>
  <subklass>Naphthalene sulfonic acids and derivatives</subklass>
  <paper-count type="integer" nil="true"/>
  <sync-id>CED0296244</sync-id>
  <structure-inchikey>SFKWASULANNHDT-UHFFFAOYSA-N</structure-inchikey>
  <structure-fingerprint>800000000000000000000000000000008180200000000000000000200000000001000000020000000004800001000000000000000000000000000000000000000000008000002020000020000000001000000004000000000000000000010000000810000000100000000000001000000400000000000000000000000000000002800000000000000080000000000100000000000000000000000000000000000800040000080000000100000000000000088000400000008020040000000100002100000000000000400080000000000004000200000000000000008000000003000040000000000400000000000000000600000000000000</structure-fingerprint>
  <structure-pattern-fingerprint>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</structure-pattern-fingerprint>
  <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAAqAAAALgAAAIABBkBoAAAAAwMBBkBoAAAA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</structure-pickle>
  <structure-indexed-at type="dateTime">2026-09-19T05:44:47Z</structure-indexed-at>
</compound>
